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With increased awareness of the diversity of transmissible spongiform encephalopathy (TSE)
strains in the ruminant population, comes an appreciation of the need for improved methods of
differential diagnosis. Exposure to bovine spongiform encephalopathy (BSE) has been associated
with the human TSE, variant Creutzfeldt–Jakob disease, emphasizing the necessity in
distinguishing low-risk TSE types from BSE. TSE type discrimination in ruminants such as cattle,
sheep, goats and deer, requires the application of several prion protein (PrP)-specific antibodies
in parallel immunochemical tests on brain homogenates or tissue sections from infected animals.
This study uses in a single incubation step, three PrP-specific antibodies and fluorescent Alexa
dye-labelled anti-mouse Fabs on a Western blot. The usual amount of brain tissue needed is
0.5 mg. This multiplex application of antibodies directed towards three different PrP epitopes
enabled differential diagnosis of all established main features of classical scrapie, BSE and
Nor98-like scrapie in sheep and goats, as well as the currently known BSE types C, H and L in
cattle. Moreover, due to an antibody-dependent dual PrP-banding pattern, for the first time
CH1641 scrapie of sheep can be reliably discriminated from the other TSE isolate types in sheep.
INTRODUCTION
Prion diseases or transmissible spongiform encephalopa-
thies (TSEs) are fatal infectious neurological disorders that
can affect humans and animals. Sometimes their pathogen-
esis is unknown, as in most cases of sporadic Creutzfeldt–
Jakob disease (CJD) in men. Often, and especially in animals
like sheep, goat, deer and cattle, transmission of TSEs is
through oral contact with contaminated food or the
environment, or through vertical transmission (Aguzzi,
2006; Prusiner, 1998; Weissmann, 2004). While the TSE
sheep scrapie has been known throughout Europe for
centuries, bovine spongiform encephalopathy (BSE) was
first recognized in 1986, in the UK. The disease and the
ensuing epidemic is thought to have stemmed from
dissemination of infectious agent in cattle feed containing
ruminant-derived protein, which had been inadequately
inactivated in destructor plants (Wells et al., 1987;
Wilesmith et al., 1988). The consequences were catastrophic
since the BSE epidemic not only gave rise to nearly 200 000
clinical cases in cattle in the UK, but had a more global
impact on livestock production and trade when it spread to
many countries. Furthermore, BSE is understood to be the
cause of a new human prion disease known as variant CJD
(vCJD), which up until now has been responsible for the
death of more than 200 people worldwide (Ironside, 2010).
While scrapie in sheep and goats is not considered to be a
human zoonosis, the fear for subclinical BSE in these
animals has led to several costly measures, especially in
Europe, to protect humans and animals against BSE
contamination and to eradicate or better control the
disease. Measures include allowing only certain animal
products to enter the food chain, testing of all cattle above
30 months of age at death for the presence of BSE, and
testing a selection of slaughtered and fallen stock sheep and
goat above the age of 18 months (Europeancommunity,
2001, 2005). The success of the measures is evident from
the dramatic decline in the incidence of BSE and, in recent
years, the substantial reduction of ruminant TSE and
human new vCJD cases.
Prion diseases are characterized by the presence and
deposition of abnormal forms of the host-encoded cellular
glycoprotein prion protein (PrPC), called PrPSc, after the
prion disease archetype scrapie. PrPC occurs relatively
universally as a glycosylphosphatidylinositol-anchoredSupplementary tables are available with the online version of this paper.
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glycoprotein in the plasma membrane of cells, although its
exact function is still unknown (Nicolas et al., 2009). Prion
disease diagnosis can be accomplished by testing brain or
lymphoid tissues for the presence of PrPSc, which unlike
PrPC is partially resistant to protease digestion. After
digestion with serine endoproteases (usually proteinase K,
PK), the resistant part of PrPSc (PrPres) can be observed by
Western blotting usually in the 17–30 kDa region as a
triple band, representing the di-, mono- and aglycosyl PrP
isoforms (Haraguchi et al., 1989; Oesch et al., 1985).
Both BSE and scrapie occur as different types and strains.
Strains of TSEs are defined by their phenotypic behaviour
after cloning the isolate in rodents (Biacabe et al., 2007;
Bruce et al., 2002; Buschmann et al., 2006; Di Bari et al.,
2008; Fraser & Dickinson, 1968; Le Dur et al., 2005;
Thackray et al., 2008), although the original isolate
phenotype frequently is strain indicative. In sheep four
TSE types have been recognized based on PrPres-banding
patterns: classical scrapie, Nor98 scrapie (a form of atypical
scrapie), BSE and CH1641 scrapie (Arsac et al., 2007;
Baron et al., 2000; Benestad et al., 2003; EFSA, 2005; Hope
et al., 1999; Klingeborn et al., 2006; Stack et al., 2002). In
cattle C-type, H-type and L-type BSE have been recognized
(Biacabe et al., 2004; Casalone et al., 2004; Jacobs et al.,
2007). Due to the remote possibility that BSE may be
present but undiagnosed in small ruminants, there is a
need for diagnostic methods that clearly differentiate these
types, so as to provide, with a high level of confidence,
assurance that the presence of BSE-like infections can be
ruled out (Europeancommunity, 2005). In principle, this
can be carried out by immunohistochemistry or biochem-
ical tests using PrP-specific antibodies. Until now, several
sections or blots are needed to evaluate partial removal of
epitopes and variations in PrP glycoprofile. In Western
blots (WB), BSE in sheep can be discriminated from
classical scrapie in sheep (Baron et al., 2000; Hill et al.,
1998; Nonno et al., 2003; Stack et al., 2002; Tang et al.,
2010; Thuring et al., 2004) based on differences in PrPres
length in the region of ovine PrP residues 80–99. CH1641
scrapie is an unusual and rare form of sheep scrapie (Foster
& Dickinson, 1988), which has N-terminal PrPres features
resembling those of BSE, while its PrPres glycosylation
characteristics seem slightly different; furthermore its
pathological and transmission properties appeared deviant
from BSE (Baron et al., 2000; Hope et al., 1999; Jeffrey
et al., 2006a; Somerville et al., 1997; Stack et al., 2002).
Differential diagnosis has thus necessitated using long
duration bioassays in mice (Europeancommunity, 2001,
2005), or immunohistochemical profiling of PrP epitope
distribution in different regions of the brain and lymphoid
follicles (Jeffrey et al., 2006b; Lezmi et al., 2006; Thuring
et al., 2005). More recently, CH1641 after passage in
transgenic mice was found by WB to feature two PrPres
populations; interestingly, this could be used for discrim-
ination from both classical scrapie and BSE (Baron &
Biacabe, 2007). It is possible that such PrPres features may
also be evident in CH1641 of original source sheep.
The aim of this paper was to investigate a multiplex
immunoblot approach (triplex-WB), for WB detection
with a set of antibodies that bind a single protein (PrP) and
are targeted at three different regions A, B and C with the
respective epitope amino acid sequences 93–97, 148–153
and 166–172 [ovine PrP sequence coding (Goldmann et al.,
1990)] so as to differentially recognize TSE type-specific
PrPres fragments (Biacabe et al., 2007). Three murine
mAbs, targeting with high affinity amino acid residues in
the N-terminal, core and C-terminal domains of ruminant
PrPres (Gavier-Widen et al., 2008; Jacobs et al., 2007;
Langeveld et al., 2006; Polak et al., 2008), were thus
employed to investigate the possibility of establishing a
clear-cut discrimination between all current main types of
TSEs in sheep and cattle (Fig. 1). Use of various fluorescent
anti-mouse Fab–Alexa conjugates enabled simultaneous
Fig. 1. Schematic diagram of major PrPres bands appearing in WB
of various TSE types and the three epitope positions used for this
study. PrPres bars approximately reflect the PK-resistant PrP
regions observed in classical scrapie, Nor98 scrapie, CH1641
scrapie, C-type BSE, L-type BSE and H-type BSE. The position of
ragged ends of PrPres fragments is indicated by open bar
segments. The position of the antibody-binding sites if present
are indicated for 12B2 (black, IgG1), L42 (hatched, IgG2a) and
SAF84 (shaded, IgG2b). These antibodies are from groups A, B
and C, respectively, as described previously (Biacabe et al., 2007).
The kDa values of the fragments are calculated from the amino acid
residue weights for the estimated ovine PrPres sequences in the
TSE types. CH1641 scrapie differs from classical scrapie in that
the 12B2 epitope is largely absent. PrPres in H-type BSE and also
supposedly CH1641 as based on the mouse bioassay data (Baron
& Biacabe, 2007) exists of two differently sized triple-band
fragments called PrPres#1 and PrPres#2. Position of potentially
present glycosyl groups is depicted (fork-like structures), as well as
the position of a glycosylphosphatidylinositol group (anchor).
Furthermore, a 7 kDa PrPres fragment recognized by 12B2 and
L42 as a component in bovine BSE samples is not depicted here
(Jacobs et al., 2007).
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measurement of binding of the three mAbs to PrPres. The
discriminatory power of the triplex-WB was evaluated by
application to brain samples from sheep, cattle and goat
affected by various scrapie and BSE types.
RESULTS
Fluorescent labels, instrument filters and test
sensitivity
Discrimination of scrapie and BSE on a single blot was
possible without recourse to signal amplification (e.g. by
use of enzyme-labelled secondary antibodies) by use of
fluorescently labelled secondary antibody conjugates. This
provided a suitable level of sensitivity, stability and
emission signal separation (zero cross-talk between differ-
ent channels) to enable triplex measurements. For detec-
tion of the emission signals of Alexa488 or Alexa647,
comparison of measurements with the dyes individually or
when all three were combined, indicated that there was no
significant level of interference (,1%). For Alexa555, the
interfering contribution of Alexa488 in the 580 emission
wavelength channel was between 0.5 and 6% of the signal
produced by the Alexa555-antibody conjugate alone. The
sensitivity of the method was considered as acceptable for
the intended purpose; the lower limit of detection was 2 ng
rec-bovinePrP, only a factor of two less sensitive than when
enzyme-labelled secondary antibody conjugates were used
(data not shown). This sensitivity was mainly accomplished
thanks to an effective background reduction using only
PVDF membranes around the gels during electrotransfer.
Linearity and assay variation
Triplex-WB measurement of PrPres in brain homogenate
from TSE-affected animals diluted threefold in homo-
genate from negative control animals exhibited highly
linear dose–response correlations (r250.9941–0.9997, Fig.
2). This indicated that data can be reliably compared
between samples in working ranges of 0.01–0.5 mg tissue
equivalents per lane. As a further indicator for assay
performance, imprecision within and between tests was
calculated by considering the 12B2/L42 ratios. Within-
assay coefficient of variation (CV%), defined as testing the
same sample threefold in three different SDS-PAGE runs
with subsequent blotting and immunotesting was between
11 and 25% (Table 1). The between-assay CV% for three
measurements of the same sample was between 25 and
40% (Table 1). Between-assay imprecision (CV%) for the
glycoprofile determinations were relatively small for the di-
and monoglycosyl fractions: ¡10% for L42 and ¡29%
for 12B2 measurements (Table 2). Taking these data
together, the triplex-WB appeared reproducible and
yielded consistent 12B2/L42 ratios for determination
irrespective of sample source (ovine, bovine, scrapie, BSE
or CH1641). Similarly, glycoprofiles produced using either
L42 or 12B2 were very similar to each other (see Table 2).
Triplex-WB patterns of different TSE isolates
The triplex-WB was applied to sample sets representing
various TSE types from both sheep (classical scrapie, Nor98
scrapie, CH1641 scrapie and experimental BSE) and cattle
(C-type, H-type and L-type). Triplex-WB assays of sheep
classical scrapie, BSE and CH1641 scrapie demonstrated
the well established triple-banding pattern in the molecular
mass 17–30 kDa range contrasting with a major 7.6 kDa
distinctive discriminative 12B2- and L42-positive bands in
Nor98 scrapie, which frequently also exhibited a 14.4 kDa
band (Fig. 3a; Supplementary Table S2, available in JGV
Online). Binding with mAbs 12B2, L42 and SAF84 was
relatively strong for classical scrapie PrPres (Fig. 3a, lane 2),
and although for mAbs L42 and SAF84 similarly strong
binding was evident for ovine experimental BSE and
CH1641 scrapie PrPres, that for 12B2 was relatively weak in
these two types (Fig. 3a, lanes 3 and 4). Interestingly,
CH1641 displayed a clearly different banding pattern from
L42 and SAF84 with L42 exhibiting a diglycosylated PrPres
fraction that is the predominant band, and with SAF84
having roughly equal intensities between di- and mono-
glycosylated PrPres (Fig. 3a, compare all lanes 4). In cattle,
L-type and C-type BSE exhibited minimal or absent
staining with 12B2 compared with that of L42 and SAF84
(Fig. 3b, lanes 1 and 2), while 12B2 staining in H-type was
relatively intense (Fig. 3b, all lanes 3). Similar to what was
Fig. 2. Dose–response curves for triplex-WB representative for
TSE samples. In this example, a moderately scrapie-positive sheep
brain homogenate was diluted over a threefold range with negative
control brain homogenate. The mixtures were digested with PK
and, after purification by 1-propanol precipitation, were analysed
on SDS-PAGE and blotting using the antibody triplex as
described: 12B2 (m), SAF84 (h) and L42 (X). The lines of best
fit and co-efficients of determination (r2) were determined by linear
least square regression analysis.
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noticed for CH1641 with respect to differentiating banding
patterns between L42 and SAF84, also H-type staining
yielded a difference in glycoprofile with a predominant
diglycosylated band with L42 and equal intensities between
di- and monoglycosylated PrPres with SAF84 (Fig. 3b,
compare all lanes 3). The different glycoprofiles obtained
between mAbs L42 and SAF84 within single samples of
CH1641 scrapie and H-type BSE is further referred to as
‘dual glycotype’.
Discriminatory analysis of isolate types from
sheep, cattle and goat
Evaluation of differences between antibody-binding profiles
for several subjects of each isolate type demonstrated
reproducible outcomes and reliable differential diagnosis
based on several parameters: (i) 12B2/L42 ratio as N-terminal
marker for PK sensitivity of PrPres (Fig. 4), (ii) relative
dominance of diglycosyl moieties using L42 (Fig. 5a), as well
as (iii) SAF84/L42 ratio at 24 kDa position as a marker for the
potential presence of different antibody-dependent glycopro-
files of PrPres or shortly dual glycotype (Fig. 5b).
For ovine isolates, the discriminating power of the 12B2/
L42 ratio was on average 12-fold between ovine scrapie
and BSE, and somewhat smaller (6-fold) between ovine
scrapie and CH1641 (Fig. 4). The discriminating power
between CH1641 and ovine classical scrapie and BSE was
further strengthened by a dual glycoprofile aspect in only
CH1641 when comparing the L42 and SAF84 staining
(Fig. 5b). The two goat-scrapie samples examined gave
similar binding profiles to those observed for classical
sheep scrapie.
For bovine isolates, the discriminative power of the 12B2/
L42 ratio was on average 14-fold between H-type BSE, and
C-type and L-type BSE (Fig. 4). The PrPres glycoprofile of L-
type BSE when tested with L42 was strikingly different from
that of H-type and C-type BSE in that the proportions of the
di- and monoglycosylated PrPres fractions were nearly equal
(Fig. 5a). The H-type cases, however, clearly exhibited
antibody-dependent glycoprofiles of PrPres by SAF84/L42
ratios which demonstrated that a substantial fraction of
signal was located at the monoglycosylated PrPres position
migrating at 24 kDa (Figs 3 and 5b).
Table 1. Within- and between-test imprecision of 12B2/L42-binding ratios that reflect the extent of N-terminal cleavage of PrPres
12B2/L42 ratios represent the proportion of antibody binding (fluorescence units) for antibodies 12B2 and L42. These values are relative, and are
not absolute indicators of the number of epitopes of 12B2 to L42 in PrPres. In the column heading are indicated the type of isolate, its signal strength
in previous tests using chemiluminescence detection (Jacobs et al., 2007), and animals identity number which can be used for sample identification
in Supplementary Table S1 (available in JGV Online). Ratio values are means±SD, with imprecision (CV%) values in parentheses. Antibodies used:
L42 (0.1 mg ml21), detection label Alexa647; 12B2 (0.1 mg ml21), detection label Alexa488.
Imprecision Ov scrapie strong
2005-18
Ov scrapie
moderate 2006-32
Bo BSE strong
NL-36
Ov BSE strong
6019325
Ov CH1641
moderate J2935
Ov CH1641
moderate J3011
Within-test 6.2±0.7* (11) 8.2±1.9* (23) 0.4±0.1D (25) 0.4±0.1* (25) 1.8±0.4* (22) 1.4±0.2d (14)
Between-test 8.8±2.2§ (25) 9.8±3.2§ (33) 0.5±0.2§ (40) 0.5±0.2§ (40) 3.5±1.2§ (34) 2.4±0.9§ (38)
*D, dWithin-test imprecision estimation was performed nine times on the same sample in NuPAGE loading buffer, but in the two cases D and d the
number is 5 and 8, respectively; the missing values were due to too low 12B2 values (below the cut-off). In these latter two cases the results were
anyway indicative for a BSE-like state.
§Between-test imprecision estimation was obtained by three successive experiments each with a new digestion with PK, SDS-PAGE run and triplex-WB.
Table 2. Between-test imprecision of glycoprofile estimations
Glycoprofiles were determined in three different experiments. The samples tested are from the same experiment as the between-test experiment of
Table 1. Values for di-, mono- and aglycosylated PrPres are expressed as percentages of the total PrPres signal, and as means±SD, with imprecision
(CV%) values in parentheses.
PrPres- moiety Ov scrapie
‘strong’
Ov scrapie
‘moderate’
Bo BSE
‘strong’
Ov BSE
‘strong’
Ov CH1641
‘moderate’
Ov CH1641
‘moderate’
L42 Di- 56±2 (4) 53±2 (4) 69±3 (4) 67±1 (1) 60±2 (3) 62±3 (5)
Mono- 28±2 (7) 30±1 (3) 20±2 (10) 21±1 (5) 30±1 (3) 30±1 (3)
A- 15±1 (7) 17±1 (6) 11±1 (9) 12±1 (8) 10±1 (10) 8±2 (25)
12B2 Di- 56±2 (4) 53±2 (4) 68±7 (10) 65±7 (11) 57±4 (7) 62±2 (3)
Mono- 28±2 (7) 31±2 (6) 24±7 (29) 22±4 (18) 28±1 (4) 27±1 (4)
A- 17±2 (12) 16±1 (6) 8±1 (13) 12±3 (25) 15±3 (20) 11±2 (18)
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DISCUSSION
The triplex immunostaining method – triplex-WB –
described here is novel in its application for analysing
different epitopes of a single protein in a single blot.
Importantly, this study contributes substantially to enhan-
cing the capability for rapid differential diagnosis of TSE
types in field isolates from sheep and cattle.
The study showed that data generated from several
antibodies with distant PrP-epitope locations can be
interpreted in a simple, sensitive and reliable manner to
enable differential diagnosis of TSE types in sheep and
cattle. This was possible for several practical reasons.
Firstly, dose–response studies demonstrated a linear
relationship between tissue concentration and binding of
the triplex target antibodies 12B2, L42 and SAF84,
indicating the possibility of maintaining differential
diagnostic capability in a manner relatively independent
of the content of PrPSc present in the sample. Secondly, the
triplex-WB procedure using non-enhanced fluorescently
labelled reagents exhibited little loss of sensitivity (by a
factor of two) compared with enzymic enhancement
procedures. This was accomplished thanks to the stability
of the labels, and to the low backgrounds on the blot
membranes. Also, there is no substrate diffusion which
with enzymically produced end products can hamper
quantification. Nevertheless, the triplex-WB system
requires care for preventing background problems by
assuring absence of precipitates in the reagents, as well as
by omitting protein-blocking reagents. Thirdly, the principle
of simultaneous measurement of binding of three different
antibodies on the same blot and the same protein reduces
the requirement for measuring several membranes. As a
consequence errors associated with differences in analyte
migration between the gels and other procedural variations
can be eliminated or minimized. To be able to perform the
triplex-WB technique it is obvious that for measuring three
fluorescent labels a high-tech imager is required with three
different lasers for excitation, as well as appropriate optical
technology.
Fig. 3. PrPres from ovine (a) and bovine (b) TSE isolate types
visualized by triplex-WB. (a) Lanes 1, Nor98 scrapie; lanes 2,
classical scrapie; lanes 3, ovine BSE; lanes 4, CH1641 scrapie.
(b) Lanes 1, L-type BSE; lanes 2, C-type BSE; lanes 3, H-type
BSE. Arrows indicate the position of the 24 kDa migration
position. Symbols d, m and a indicate the migration positions of
di-, mono- and aglycosylated forms of PrPres. Each of the three
antibody combinations used is indicated above the triplex-WB
generated lane-sets.
Fig. 4. Comparing the presence of N terminus of PrPres in different
isolate types from sheep (Ov), goat (Gt) and cattle (Bo) by triplex-
WB analysis. A high 12B2/L42 ratio reflects a relative strong
resistance of the PrPSc N terminus to proteolysis. The isolate types
used are indicated. The origin of these isolates are detailed in
Supplementary Table S1. Values represent mean±SD (n5no.
cases tested). Differences between ratios for ovine- and goat-
scrapie isolate types compared with experimental ovine BSE (aa,
P,0.001) and CH1641 (bb, P,0.001, only two samples) were
statistically significant. Similarly, the ratio for bovine BSE H-type
was statistically different from those for C-type (cc, P,0.001) and
L-type (d, P,0.01).
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TSE type features in small ruminants
In the current study, the molecular differentiation in sheep
by WB between classical scrapie, Nor98 scrapie and BSE in
small ruminants was as effective as in the current methods
for discrimination. Nor98 scrapie PrPres is characterized by
the presence of a major 7–8 kDa band that is reactive with
group A antibody 12B2 (comparable to the species-
dependent mAb P4 used elsewhere), and group B antibody
L42 (Benestad et al., 2003; Biacabe et al., 2007; Gretzschel
et al., 2006; Klingeborn et al., 2006; Polak et al., 2010).
Classical scrapie can be recognized by the equally strong
reactivity between group A and B antibodies 12B2 and L42
(or between P4 and 6H4) (Langeveld et al., 2006; Stack
et al., 2002; Thuring et al., 2004). However, until now it has
not proved readily possible to distinguish PrPres from
CH1641 scrapie and ovine BSE with respect to virtual
absence of the P4-binding epitope, one of the two
established hallmarks for BSE cases (Stack et al., 2002).
Discrimination between CH1641 scrapie and BSE was
Fig. 5. PrPres glycoprofile of sheep and cattle TSE isolates characterized using antibodies L42 and SAF84 in triplex-WB. (a)
Relative abundance of di- and monoglycosylated PrPres for individual ovine and bovine TSE cases, detected by mAb L42.
Values are percentages per PrPres band. Only in case of L-type BSE di- and monoglycosyl moieties occur in near equal
proportions (arrows). In contrast, the diglycosyl moiety is the predominant PrPres form in classical sheep and CH1641 scrapie,
and in cattle C-type and H-type BSE. (b) The ratio of SAF84/L42 binding to mono- and diglycosylated PrPres in TSE isolates.
Only for CH1641 scrapie and H-type BSE there was evidence of a substantial difference between binding associated with the
monoglycosylated PrPres form (dual glycotype antibody-binding behaviour, arrows), thus concerning the band at the 24 kDa
position (arrowed in Fig. 3).
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further obscured by the second hallmark for BSE that is a
relative predominant diglycosyl fraction (.60%), while
this fraction was slightly lower in CH1641 PrPres using
group B antibodies (Baron et al., 1999, 2000; Gretzschel
et al., 2005; Lezmi et al., 2004; Stack et al., 2002). Recently,
a novel molecular aspect in CH1641 scrapie became
obvious after transgenic TgOvPrP4 mice, which express
ovine wild-type PrP, had been inoculated with brain
material from either CH1641 experimentally infected sheep
or some natural unusual ovine scrapie cases (Baron &
Biacabe, 2007). It was concluded that this type of isolate
carried two populations of PrPres: PrPres#1 and PrPres#2.
Since PrPres#1 and PrPres#2 are both recognized by group
C antibodies like SAF84, while group B antibodies like L42
only bind to PrPres#1, SAF84 will yield a different
glycoprofile from that produced with L42, a phenomenon
that has been described for H-type BSE (see Fig. 1 for
structural explanation). In keeping with these observations,
we also found in PrPres material from CH1641-infected
sheep indications for the existence of a dual population of
PrPres types. Significant for discrimination, binding profiles
for BSE and classical scrapie were similar whether SAF84 or
L42 was used, whereas for CH1641 glycoprofiles were
characteristically different for the two mAbs. Thus, reliable
discrimination appeared possible now between classical
scrapie, CH1641 scrapie and BSE in sheep. The finding that
experimental CH1641 scrapie in sheep now can be
faithfully differentiated from experimental BSE in sheep
using this dual glycotype aspect as observed with the mAbs
L42 and SAF84 is new and important in decision making
when small ruminant TSE surveillance encounters field
cases with BSE-like appearance (Eloit et al., 2005; Jeffrey
et al., 2006b; Lezmi et al., 2004).
BSE type features in cattle
In cattle samples, single blot triplex-WB yielded consis-
tently the antibody-binding patterns for C-type, L-type and
H-type BSE isolates as expected when tested in three
separate blots (Jacobs et al., 2007). C-type and L-type
isolates showed very limited presence of the 12B2 epitope
compared with the L42 core epitope. Furthermore, L-type
samples showed a relatively high monoglycosylated frac-
tion of PrPres (signal intensity equal to the diglycosyl
fraction) with both antibodies L42 (group B) and SAF84
(group C) (Fig. 5). H-type BSE exhibited relatively elevated
levels of the 12B2 binding, indicative for increased
resistance to N-terminal cleavage by PK compared with
C-type BSE, and in this respect comparable with that found
in classical scrapie (Fig. 4). However, H-type BSE, like
CH1641 scrapie, was notable by a dual glycotype aspect
with antibodies L42 and SAF84 (Fig. 5b).
Discriminators for ruminant TSE isolate typing by
PrPres analysis
The extent of which TSE types can be most simply
differentiated by triplex-WB is readily illustrated for sheep
and cattle by the spatial separation made evident by
comparing the relative amounts of N-terminal epitope to
core epitope (12B2/L42 ratio) with the binding properties
as represented by the SAF84/L42 ratio at the 24 kDa
position (Fig. 6a). In sheep, CH1641 can be easily
distinguished from BSE by the difference between SAF84/
L42 ratio values. Nor98 scrapie is characterized by a main
PrPres band at 7–8 kDa (Fig. 3). In cattle, the values for
both 12B2/L42 and SAF84/L42 ratios are substantially
elevated in H-type BSE compared with C-type and L-type
BSE (Fig. 6b). L-type BSE can be discriminated from C-
type by equal di- and monoglycosyl moiety fractions (Fig.
5a). It can be envisaged that the technique will be useful in
the typing of the human sCJD types as well as the vCJD
samples e.g. sCJD type I, will be characterized by a high
12B2 binding (like scrapie and H-type BSE), while sCJD
type II differs from vCJD by a relatively low diglycosyl
moiety (like L-type BSE) (Notari et al., 2007).
Indeed, the novel triplex-WB procedure proved capable of
distinguishing all established forms of TSE isolates in
livestock: classical scrapie, Nor98 scrapie, BSE and CH1641
scrapie in sheep and C-type, H-type and L-type BSE in
cattle. The assay principle may thus prove invaluable in
reducing ambiguity in disease classification and thus assist
in reducing the need to perform animal bioassays for strain
typing to exclude the potential presence or absence of BSE-
like infections. The technique will also be attractive for
application in future PrPSc and PrPres typing efforts for
tissue section analyses and in vitro assays as well.
METHODS
Chemicals and reagents. Chemicals were purchased from Merck
unless otherwise specified, and were at least analytical reagent grade.
Reagents for SDS-PAGE and the Molecular Probes Zenon kits for
mouse IgG class-specific detection, containing isotype-specific goat
anti-mouse-Fc Fab-Alexa Fluor conjugate (Zenon Alexa Fluor 647
anti-Mouse IgG2a, catalogue no. Z25108; Zenon Alexa Fluor 555
anti-Mouse IgG2b, catalogue no. Z25205 and Zenon Alexa Fluor 488
anti-Mouse IgG1, catalogue no. Z25002) were purchased from
Invitrogen. Purified recombinant bovine PrP was obtained from
Prionics AG, Schlieren, Switzerland.
Antibodies and their epitope specificities.Murine anti-PrP mAbs
12B2 IgG1, L42 IgG2a (L42 appeared to be an IgG2a class antibody,
and was erroniously reported as an IgG1 class in Harmeyer et al.,
1998) and SAF84 IgG2b were chosen for simultaneous use in triplex-
WB (Feraudet et al., 2005; Harmeyer et al., 1998; Langeveld et al.,
2006), since these met the potential requirements for TSE type
discrimination, exhibited high affinity to ruminant PrP and
represented different IgG classes (Fig. 1). The epitope specificities of
these mAbs were mapped by Pepscan analyses with solid phase bound
15-mer PrP-based peptides (Langeveld et al., 2006; Slootstra et al.,
1996): 12B2, L42 and SAF84 are specific for epitopes in PrP
93WGQGG97, 148YEDRYY153 and 166YRPVDQY172, respectively
[ovine PrP sequence numbering (Goldmann et al., 1990)].
Tissues, homogenates, digestion and partial purification.
Sheep, goat and cattle brainstem tissues were obtained either from
experimental infections or from slaughterhouse or fallen stock
material as part of routine screening programmes for TSE; the
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routine preliminary testing of samples was performed using a
commercially available WB assay procedure (Prionics-Check
Western blot; Schaller et al., 1999). Data on individual samples can
be found in a separate table, including German and Polish BSE cases
(Supplementary Table S1). The TSE status was further confirmed by
immunohistochemistry. Tissue from CH1641 scrapie was prepared
through intracerebral challenge in three Cheviot sheep (provided by
Foster & Hunter, Edinburgh). First passage and second passage ovine
BSE material was prepared by combined intercerebral, intravenous
and intraperitoneal inoculation of ARQ/ARQ sheep, starting with
bovine BSE brain material TSE-free collected from a Dutch case (NL-
62) with clinical signs. Two confirmed positive-scrapie goats from a
Dutch recreational city farm were also used, one of which in clinical
condition. One H-type BSE sample was generated by intracerebral
inoculation of obex material from a Dutch H-type case NL-22 (Jacobs
et al., 2007). Confirmed TSE-negative brainstem tissues from a cow
and a sheep served as negative controls. TSE-positive tissues were
stored at 270 uC and negative tissues at 220 uC. Ten per cent
homogenates were prepared in lysis buffer and digested with PK at
37 uC as described previously (Jacobs et al., 2007). Partial PrPres
purification was achieved by precipitation in 1-propanol (34871;
Sigma-Aldrich) centrifugation at 16 000 g for 5 min in a Biofuge Pico
centrifuge (Heraeus) at room temperature. After discarding the
supernatant, pellets contained 10 mg tissue equivalents (TE).
SDS-PAGE and WB. PrPres pellets were resuspended and dissolved
in 100 ml NuPAGE loading buffer 16, including reducing agent just
before use [141 mM Tris base (93362; Sigma), 106 mM Tris/HCl
(93287; Sigma), 73 mM lithium dodecyl sulfate (62554; Fluka),
1.09 M glycerol (49767; Fluka), 0.51 mM EDTA, without front
marker dyes, with NuPAGE Sample Reducing Agent 16 (NP0009;
Invitrogen)]. The sample was denatured by heating for 10 min at
96 uC. After cooling down to room temperature, the sample was
centrifuged at 16 000 g for 5 min in a Biofuge Pico microcentrifuge at
room temperature. Sample supernatants (5 ml, 500 mg TE per lane)
were then subjected to SDS-PAGE by using 17-well NuPAGE 12%
Bistris 1.0 mm precast gels. As molecular mass reference, a 5 ml
aliquot from a 50 times dilution of SeeBlue Pre-Stained Standard
(LC5625; Invitrogen) was applied to a separate gel lane.
Electrophoresis was performed with 2-morpholinoethanesulfonic
acid SDS running buffer with antioxidant. Electrotransfer onto
minimally fluorescent PVDF membrane with 0.45 mm pore size
(Immobilon-FL; Millipore) was performed in a tank-blotter (Trans-
Blot Electrophoretic Transfer Cell; Bio-Rad) for 60 min at 150 V with
temperature control at 8 uC and pre-cooled transfer buffer pH 8.3
(25 mM Tris, 192 mM glycine, 10% methanol). A pre-wetted PVDF
transfer sheet and the gel was sandwiched between two other sheets
of pre-wetted PVDF membrane. After transfer, the blot was washed
three times for 5 min in washing buffer [25 mM Tris base, 0.137 M
NaCl, 0.003 M KCl, adjusted to pH 7.4 with HCl, 0.5% (v/v)
Tween-20].
Triplex antibody incubation and detection on WB (triplex-WB).
The product information protocol from the Zenon Mouse IgG
Labelling kits was followed, and a standard 3 : 1 molar ratio Fab :mAb
was used. Incubations were performed in the dark at room
Fig. 6. Diagram to illustrate two PrPres aspects that can provide
discrimination between single TSE isolate types in sheep or cattle.
The 12B2/L42 ratio on the vertical axis shows the aspect of N-
terminal processing in the 12B2 epitope relative to the PrPres core
(L42 epitope); the SAF84/L42 ratio on the horizontal axis
demonstrates the extent of dual glycotype where SAF84 can bind
to all C-terminal fragments of PrPres and L42 to all PrPres
fragments except the supposed C-terminal PrPres#2 populations
of CH1641 scrapie and H-type BSE (see also Fig. 1). For each
dataset of TSE type isolates, also the mean±SD is shown. L-type
BSE can be discriminated from C-type BSE by its high
monoglycosyl PrPres content relative to that of the diglycosyl
fraction (see Fig. 5a). (a) Data points are from classical scrapie
(solid diamonds, n58), experimental BSE (open diamonds, n54)
and CH1641-affected sheep (grey diamonds, n53) and two goat
with classical scrapie (crossed symbols). (b) Data points are from
cattle affected with C-type (open circles, n58), L-type (solid
circles, n53) and H-type BSE (grey circles, n53). Ovine classical
scrapie from (a) is included as a reference point to facilitate
comparisons between panels (a) and (b).
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temperature. The Zenon Complex Formation protocol was per-
formed in separate tubes for each antibody. Antibodies 12B2, L42 and
SAF84 were used at respective concentrations of 0.1, 0.1 and 0.5 mg
IgG ml21. For immunocomplex formation, the appropriate amount
of individual purified mAbs and proportion of corresponding Zenon
Alexa Fluor-labelled anti-mouse isotype was added to 10 ml washing
buffer and mixed. Following a 5 min incubation, an equal amount of
Zenon-blocking reagent was added to each, mixed and incubated for
5 min. The three blocked Zenon complexes were then diluted in
washing buffer, mixed with each other in the correct ratio, added to
the blot and then incubated for 1 h on a rocking platform. Blots were
then washed four times for 5 min with washing buffer and left to dry
in a free hanging condition in the dark overnight. Dried blots were
inserted into development folders (T2258; Applied Biosystems) and
visualized by fluorescence scanning (pixel size 200 mm) on a Typhoon
Trio variable-mode imager (Amersham Biosciences) set at focal plane
platen. Red, green and blue lasers were used for excitation (633, 532
and 488 nm) with corresponding emission filters (670BP30, 580BP30
and 520BP40). For each channel the photomultiplier tube was set at
400 V and normal sensitivity.
Quantification, calculation and statistical analysis. The data files
with light emission values from the Typhoon scanner were analysed
using ImageQuant software (Molecular Dynamics/Amersham Bio-
sciences) and images were quantified by positioning either rectangular
areas around (for mAb ratio calculation) or lines over (for
glycoprofile calculation) triple bands in each lane. The light emission
values measured in the rectangles were further processed for
background correction of each lane using the local median correction
option; data were exported to Excel (Microsoft). A mean general
background value was established for each blot by placing also four
rectangles (blanks) at blot sites with minimal fluorescence. The light
emission noise was considered as above background when mean
values obtained in the four blanks were .2.5 times general
background. For glycoprofile calculation at the line overlays, light
emission values measured for each of the three bands of a triple
PrPres-band pattern were expressed as a percentage of total light
emission of the three bands. Assay imprecision (CV%) for a set of
data was calculated as coefficient of variation, which is expressed as
[SD/mean6100%].
Proprietary software was used for statistical analyses (Instat
Biostatistics from Graph-Pad Software). One-way analysis of variance
was used to establish whether variations between groups of data
(12B2/L42 ratio values) were greater than expected. In this case,
differences between pairs of groups were considered statistically
significant if probability for equality was ,0.05 in multiple-
comparisons tests (Student–Newman–Keuls test).
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